首页> 外文期刊>Expert opinion on investigational drugs >Antiviral applications of RNAi for coronavirus
【24h】

Antiviral applications of RNAi for coronavirus

机译:RNAi在冠状病毒中的抗病毒应用

获取原文
获取原文并翻译 | 示例
       

摘要

Until the appearance of severe acute respiratory syndrome (SARS).caused by the SARS coronavirus (SARS-CoV)in early 2003.coronavirus infection was not considered to be serious enough to be controlled by either vaccination or specific antiviral therapy. It is now believed that the availability of antiviral drugs effective against SARS-CoV will be crucial for the control of future SARS outbreaks. Recently.RNA interference has been successfully used as a more specific and efficient method for gene silencing. RNA interference induced by small interfering RNA can inhibit the expression of viral antigens and so provides a new approach to the therapy of pathogenic viruses. This review provides an overview of current information on coronavirus and the application of small interfering RNA in viral therapeutics.with particular reference to SARS-CoV.
机译:直到2003年初由SARS冠状病毒(SARS-CoV)引起的严重急性呼吸道综合症(SARS)出现,冠状病毒的感染才被认为严重到无法通过疫苗接种或特异性抗病毒治疗来控制。现在认为,有效抗SARS-CoV的抗病毒药物对于控制未来的SARS爆发至关重要。最近,RNA干扰已被成功地用作基因沉默的更特异性和更有效的方法。小分子干扰RNA诱导的RNA干扰可以抑制病毒抗原的表达,从而为病原病毒的治疗提供了一种新方法。这篇综述概述了有关冠状病毒的最新信息以及小干扰RNA在病毒治疗中的应用,特别是针对SARS-CoV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号